missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VEGF 145 (aa 27-171) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 7626-VE-010/CF
Additional Details : Weight : 0.00970kg
Description
The Recombinant Human VEGF 145 (aa 27-171) Protein is derived from E. coli. The Recombinant Human VEGF 145 (aa 27-171) Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in HCl. | |
17 kDa (monomer) | |
10μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Unconjugated | |
95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
7422 | |
VEGF 145 (aa 27-171) | |
E. coli-derived human VEGF protein Ala27-Arg171,with an N-terminal Met | |
Disulfide-linked homodimer | |
Recombinant |